Ever wondered if Quest Diagnostics stock is actually a bargain right now, or just riding the latest market waves? You are in the right place to get some clarity. The stock has made an impressive move, ...
The Autoimmune Disease Diagnostics industry is set for significant growth, projected to leap from US$ 5.70 billion in 2024 to ...
This week, I will share some tips for establishing milestone goals that make sense and continue to inspire action. Plus, I'll ...
A federal appellate court refused to revive claims that Quest Diagnostics violated a wiretap law by allegedly sharing web users' browsing information with Meta, via its analytics pixel.
Quest Diagnostics' fair value estimate remains steady at $197.25 per share, with only a slight uptick in the discount rate. This reflects minimal change in the firm's valuation assessment. While the ...
Revenue and Adjusted EBITDA improvements of 6.4% and 9.5%, respectively from the prior quarter Reduced debt by $4.6 million in the quarter, bringing year-to-date debt reduction to $11.2 million ...
What To Know: While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the company lowered its GAAP earnings per share guidance to a range of $8.58 to $8.66 from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback